Linscomb Wealth Inc. Raises Position in Waters Co. (NYSE:WAT)

Linscomb Wealth Inc. boosted its holdings in shares of Waters Co. (NYSE:WAT) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,135 shares of the medical instruments supplier’s stock after buying an additional 103 shares during the period. Linscomb Wealth Inc.’s holdings in Waters were worth $3,018,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp grew its holdings in shares of Waters by 1.9% during the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock worth $927,700,000 after purchasing an additional 49,194 shares in the last quarter. Geode Capital Management LLC lifted its position in Waters by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock valued at $508,123,000 after purchasing an additional 16,703 shares during the last quarter. Janus Henderson Group PLC grew its stake in Waters by 0.7% in the 3rd quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier’s stock worth $318,717,000 after buying an additional 6,256 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Waters by 11.1% in the 4th quarter. Principal Financial Group Inc. now owns 728,534 shares of the medical instruments supplier’s stock worth $270,272,000 after buying an additional 72,515 shares during the last quarter. Finally, Impax Asset Management Group plc increased its holdings in shares of Waters by 10.6% in the 4th quarter. Impax Asset Management Group plc now owns 714,155 shares of the medical instruments supplier’s stock worth $264,937,000 after buying an additional 68,509 shares during the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

WAT has been the subject of several research reports. Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price for the company in a research report on Friday, January 10th. StockNews.com cut Waters from a “buy” rating to a “hold” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft increased their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. boosted their target price on Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, Bank of America reduced their price target on shares of Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Waters has an average rating of “Hold” and a consensus price target of $390.40.

Waters Trading Down 3.0 %

Shares of WAT opened at $373.26 on Friday. The stock has a market capitalization of $22.16 billion, a P/E ratio of 34.85, a PEG ratio of 3.79 and a beta of 1.01. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The firm has a fifty day simple moving average of $389.86 and a two-hundred day simple moving average of $367.00. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, research analysts anticipate that Waters Co. will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.